Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.
Identifieur interne : 001632 ( Main/Exploration ); précédent : 001631; suivant : 001633Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.
Auteurs : George S. Georgiadis [Grèce] ; Christos Argyriou [Grèce] ; Selcuk Baktiroglu [Turquie] ; Miltos K. Lazarides [Grèce] ; Alexandros Mallios [France] ; Jan Hm Tordoir [Pays-Bas]Source :
- The journal of vascular access [ 1724-6032 ] ; 2020.
Descripteurs français
- KwdFr :
- Anastomose chirurgicale artérioveineuse (effets indésirables), Appréciation des risques (MeSH), Betacoronavirus (pathogénicité), Cathétérisme veineux central (effets indésirables), Dialyse rénale (effets indésirables), Délai jusqu'au traitement (MeSH), Exposition professionnelle (effets indésirables), Exposition professionnelle (prévention et contrôle), Facteurs de risque (MeSH), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (transmission), Infections à coronavirus (virologie), Maladies du rein (diagnostic), Maladies du rein (thérapie), Pandémies (prévention et contrôle), Pneumopathie virale (diagnostic), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (transmission), Pneumopathie virale (virologie), Prise de décision clinique (MeSH), Santé au travail (MeSH), Sécurité des patients (MeSH), Sélection de patients (MeSH), Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle), Transmission de maladie infectieuse du professionnel de santé au patient (prévention et contrôle), Virulence (MeSH).
- MESH :
- diagnostic : Infections à coronavirus, Maladies du rein, Pneumopathie virale.
- effets indésirables : Anastomose chirurgicale artérioveineuse, Cathétérisme veineux central, Dialyse rénale, Exposition professionnelle.
- pathogénicité : Betacoronavirus.
- prévention et contrôle : Exposition professionnelle, Infections à coronavirus, Pandémies, Pneumopathie virale, Transmission de maladie infectieuse du patient au professionnel de santé, Transmission de maladie infectieuse du professionnel de santé au patient.
- thérapie : Maladies du rein.
- virologie : Infections à coronavirus, Pneumopathie virale.
- transmission : Appréciation des risques, Délai jusqu'au traitement, Facteurs de risque, Humains, Infections à coronavirus, Pneumopathie virale, Prise de décision clinique, Santé au travail, Sécurité des patients, Sélection de patients, Virulence.
English descriptors
- KwdEn :
- Arteriovenous Shunt, Surgical (adverse effects), Betacoronavirus (pathogenicity), Catheterization, Central Venous (adverse effects), Clinical Decision-Making (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Coronavirus Infections (virology), Humans (MeSH), Infectious Disease Transmission, Patient-to-Professional (prevention & control), Infectious Disease Transmission, Professional-to-Patient (prevention & control), Kidney Diseases (diagnosis), Kidney Diseases (therapy), Occupational Exposure (adverse effects), Occupational Exposure (prevention & control), Occupational Health (MeSH), Pandemics (prevention & control), Patient Safety (MeSH), Patient Selection (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (prevention & control), Pneumonia, Viral (transmission), Pneumonia, Viral (virology), Renal Dialysis (adverse effects), Risk Assessment (MeSH), Risk Factors (MeSH), Time-to-Treatment (MeSH), Virulence (MeSH).
- MESH :
- adverse effects : Arteriovenous Shunt, Surgical, Catheterization, Central Venous, Occupational Exposure, Renal Dialysis.
- diagnosis : Coronavirus Infections, Kidney Diseases, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- prevention & control : Coronavirus Infections, Infectious Disease Transmission, Patient-to-Professional, Infectious Disease Transmission, Professional-to-Patient, Occupational Exposure, Pandemics, Pneumonia, Viral.
- therapy : Kidney Diseases.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Clinical Decision-Making, Humans, Occupational Health, Patient Safety, Patient Selection, Risk Assessment, Risk Factors, Time-to-Treatment, Virulence.
Abstract
The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'.
DOI: 10.1177/1129729820926860
PubMed: 32390495
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.</title><author><name sortKey="Georgiadis, George S" sort="Georgiadis, George S" uniqKey="Georgiadis G" first="George S" last="Georgiadis">George S. Georgiadis</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Argyriou, Christos" sort="Argyriou, Christos" uniqKey="Argyriou C" first="Christos" last="Argyriou">Christos Argyriou</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Baktiroglu, Selcuk" sort="Baktiroglu, Selcuk" uniqKey="Baktiroglu S" first="Selcuk" last="Baktiroglu">Selcuk Baktiroglu</name><affiliation wicri:level="1"><nlm:affiliation>General Surgery Clinic, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>General Surgery Clinic, Istanbul Medical Faculty, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Lazarides, Miltos K" sort="Lazarides, Miltos K" uniqKey="Lazarides M" first="Miltos K" last="Lazarides">Miltos K. Lazarides</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Mallios, Alexandros" sort="Mallios, Alexandros" uniqKey="Mallios A" first="Alexandros" last="Mallios">Alexandros Mallios</name><affiliation wicri:level="3"><nlm:affiliation>Service de Chir Vasc, Institut Mutualiste Montsouris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Chir Vasc, Institut Mutualiste Montsouris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tordoir, Jan Hm" sort="Tordoir, Jan Hm" uniqKey="Tordoir J" first="Jan Hm" last="Tordoir">Jan Hm Tordoir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32390495</idno><idno type="pmid">32390495</idno><idno type="doi">10.1177/1129729820926860</idno><idno type="wicri:Area/Main/Corpus">001360</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001360</idno><idno type="wicri:Area/Main/Curation">001360</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001360</idno><idno type="wicri:Area/Main/Exploration">001360</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.</title><author><name sortKey="Georgiadis, George S" sort="Georgiadis, George S" uniqKey="Georgiadis G" first="George S" last="Georgiadis">George S. Georgiadis</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Argyriou, Christos" sort="Argyriou, Christos" uniqKey="Argyriou C" first="Christos" last="Argyriou">Christos Argyriou</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Baktiroglu, Selcuk" sort="Baktiroglu, Selcuk" uniqKey="Baktiroglu S" first="Selcuk" last="Baktiroglu">Selcuk Baktiroglu</name><affiliation wicri:level="1"><nlm:affiliation>General Surgery Clinic, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>General Surgery Clinic, Istanbul Medical Faculty, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Lazarides, Miltos K" sort="Lazarides, Miltos K" uniqKey="Lazarides M" first="Miltos K" last="Lazarides">Miltos K. Lazarides</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis</wicri:regionArea><wicri:noRegion>Alexandroupolis</wicri:noRegion></affiliation></author><author><name sortKey="Mallios, Alexandros" sort="Mallios, Alexandros" uniqKey="Mallios A" first="Alexandros" last="Mallios">Alexandros Mallios</name><affiliation wicri:level="3"><nlm:affiliation>Service de Chir Vasc, Institut Mutualiste Montsouris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Chir Vasc, Institut Mutualiste Montsouris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tordoir, Jan Hm" sort="Tordoir, Jan Hm" uniqKey="Tordoir J" first="Jan Hm" last="Tordoir">Jan Hm Tordoir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author></analytic><series><title level="j">The journal of vascular access</title><idno type="eISSN">1724-6032</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arteriovenous Shunt, Surgical (adverse effects)</term><term>Betacoronavirus (pathogenicity)</term><term>Catheterization, Central Venous (adverse effects)</term><term>Clinical Decision-Making (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Coronavirus Infections (virology)</term><term>Humans (MeSH)</term><term>Infectious Disease Transmission, Patient-to-Professional (prevention & control)</term><term>Infectious Disease Transmission, Professional-to-Patient (prevention & control)</term><term>Kidney Diseases (diagnosis)</term><term>Kidney Diseases (therapy)</term><term>Occupational Exposure (adverse effects)</term><term>Occupational Exposure (prevention & control)</term><term>Occupational Health (MeSH)</term><term>Pandemics (prevention & control)</term><term>Patient Safety (MeSH)</term><term>Patient Selection (MeSH)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (transmission)</term><term>Pneumonia, Viral (virology)</term><term>Renal Dialysis (adverse effects)</term><term>Risk Assessment (MeSH)</term><term>Risk Factors (MeSH)</term><term>Time-to-Treatment (MeSH)</term><term>Virulence (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anastomose chirurgicale artérioveineuse (effets indésirables)</term><term>Appréciation des risques (MeSH)</term><term>Betacoronavirus (pathogénicité)</term><term>Cathétérisme veineux central (effets indésirables)</term><term>Dialyse rénale (effets indésirables)</term><term>Délai jusqu'au traitement (MeSH)</term><term>Exposition professionnelle (effets indésirables)</term><term>Exposition professionnelle (prévention et contrôle)</term><term>Facteurs de risque (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (virologie)</term><term>Maladies du rein (diagnostic)</term><term>Maladies du rein (thérapie)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (transmission)</term><term>Pneumopathie virale (virologie)</term><term>Prise de décision clinique (MeSH)</term><term>Santé au travail (MeSH)</term><term>Sécurité des patients (MeSH)</term><term>Sélection de patients (MeSH)</term><term>Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle)</term><term>Transmission de maladie infectieuse du professionnel de santé au patient (prévention et contrôle)</term><term>Virulence (MeSH)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Arteriovenous Shunt, Surgical</term><term>Catheterization, Central Venous</term><term>Occupational Exposure</term><term>Renal Dialysis</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Kidney Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Maladies du rein</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anastomose chirurgicale artérioveineuse</term><term>Cathétérisme veineux central</term><term>Dialyse rénale</term><term>Exposition professionnelle</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Infectious Disease Transmission, Patient-to-Professional</term><term>Infectious Disease Transmission, Professional-to-Patient</term><term>Occupational Exposure</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Exposition professionnelle</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Transmission de maladie infectieuse du patient au professionnel de santé</term><term>Transmission de maladie infectieuse du professionnel de santé au patient</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Kidney Diseases</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Maladies du rein</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Decision-Making</term><term>Humans</term><term>Occupational Health</term><term>Patient Safety</term><term>Patient Selection</term><term>Risk Assessment</term><term>Risk Factors</term><term>Time-to-Treatment</term><term>Virulence</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="fr"><term>Appréciation des risques</term><term>Délai jusqu'au traitement</term><term>Facteurs de risque</term><term>Humains</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Prise de décision clinique</term><term>Santé au travail</term><term>Sécurité des patients</term><term>Sélection de patients</term><term>Virulence</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32390495</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1724-6032</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The journal of vascular access</Title><ISOAbbreviation>J Vasc Access</ISOAbbreviation></Journal><ArticleTitle>Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.</ArticleTitle><Pagination><MedlinePgn>536-538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1129729820926860</ELocationID><Abstract><AbstractText>The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georgiadis</LastName><ForeName>George S</ForeName><Initials>GS</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-1274-3445</Identifier><AffiliationInfo><Affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyriou</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baktiroglu</LastName><ForeName>Selcuk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Surgery Clinic, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazarides</LastName><ForeName>Miltos K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3458-7412</Identifier><AffiliationInfo><Affiliation>Department of Vascular Surgery, 'Democritus' University of Thrace, University General Hospital of Evros, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallios</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0641-6050</Identifier><AffiliationInfo><Affiliation>Service de Chir Vasc, Institut Mutualiste Montsouris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tordoir</LastName><ForeName>Jan Hm</ForeName><Initials>JH</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0766-282X</Identifier><AffiliationInfo><Affiliation>Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Access</MedlineTA><NlmUniqueID>100940729</NlmUniqueID><ISSNLinking>1129-7298</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001166" MajorTopicYN="Y">Arteriovenous Shunt, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002405" MajorTopicYN="Y">Catheterization, Central Venous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017758" MajorTopicYN="N">Infectious Disease Transmission, Patient-to-Professional</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017757" MajorTopicYN="N">Infectious Disease Transmission, Professional-to-Patient</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="N">Occupational Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016272" MajorTopicYN="N">Occupational Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19 vascular guidelines</Keyword><Keyword MajorTopicYN="N">arteriovenous fistula</Keyword><Keyword MajorTopicYN="N">catheters</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">dialysis access</Keyword><Keyword MajorTopicYN="N">economics and health services</Keyword><Keyword MajorTopicYN="N">ethics and end-of-life issues</Keyword><Keyword MajorTopicYN="N">pre-dialysis patients</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32390495</ArticleId><ArticleId IdType="doi">10.1177/1129729820926860</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Grèce</li><li>Pays-Bas</li><li>Turquie</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><country name="Grèce"><noRegion><name sortKey="Georgiadis, George S" sort="Georgiadis, George S" uniqKey="Georgiadis G" first="George S" last="Georgiadis">George S. Georgiadis</name></noRegion><name sortKey="Argyriou, Christos" sort="Argyriou, Christos" uniqKey="Argyriou C" first="Christos" last="Argyriou">Christos Argyriou</name><name sortKey="Lazarides, Miltos K" sort="Lazarides, Miltos K" uniqKey="Lazarides M" first="Miltos K" last="Lazarides">Miltos K. Lazarides</name></country><country name="Turquie"><noRegion><name sortKey="Baktiroglu, Selcuk" sort="Baktiroglu, Selcuk" uniqKey="Baktiroglu S" first="Selcuk" last="Baktiroglu">Selcuk Baktiroglu</name></noRegion></country><country name="France"><region name="Île-de-France"><name sortKey="Mallios, Alexandros" sort="Mallios, Alexandros" uniqKey="Mallios A" first="Alexandros" last="Mallios">Alexandros Mallios</name></region></country><country name="Pays-Bas"><noRegion><name sortKey="Tordoir, Jan Hm" sort="Tordoir, Jan Hm" uniqKey="Tordoir J" first="Jan Hm" last="Tordoir">Jan Hm Tordoir</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001632 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001632 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32390495
|texte= Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32390495" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |